UA79972C2 - Спосіб одержання (-)-(s)-3-[1-(диметиламіно)етил]феніл-n-етил-n-метилкарбамату та його гідротартрату - Google Patents
Спосіб одержання (-)-(s)-3-[1-(диметиламіно)етил]феніл-n-етил-n-метилкарбамату та його гідротартрату Download PDFInfo
- Publication number
- UA79972C2 UA79972C2 UAA200500538A UA2005000538A UA79972C2 UA 79972 C2 UA79972 C2 UA 79972C2 UA A200500538 A UAA200500538 A UA A200500538A UA 2005000538 A UA2005000538 A UA 2005000538A UA 79972 C2 UA79972 C2 UA 79972C2
- Authority
- UA
- Ukraine
- Prior art keywords
- formula
- compound
- ethyl
- differs
- interaction
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 24
- 238000004519 manufacturing process Methods 0.000 title description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 title 1
- CVMUDVRZCFIUOF-NSHDSACASA-N [3-[(1S)-1-(dimethylamino)ethyl]phenyl]methyl-ethylcarbamic acid Chemical compound CCN(C(O)=O)CC1=CC=CC([C@H](C)N(C)C)=C1 CVMUDVRZCFIUOF-NSHDSACASA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 31
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 claims abstract description 11
- 159000000011 group IA salts Chemical class 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 229960004136 rivastigmine Drugs 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 15
- 230000003993 interaction Effects 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000006268 reductive amination reaction Methods 0.000 claims description 4
- YRNDGUSDBCARGC-UHFFFAOYSA-N 2-methoxyacetophenone Chemical compound COCC(=O)C1=CC=CC=C1 YRNDGUSDBCARGC-UHFFFAOYSA-N 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 17
- 239000013078 crystal Substances 0.000 description 16
- 238000003756 stirring Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 9
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- GQZXRLWUYONVCP-UHFFFAOYSA-N 3-[1-(dimethylamino)ethyl]phenol Chemical compound CN(C)C(C)C1=CC=CC(O)=C1 GQZXRLWUYONVCP-UHFFFAOYSA-N 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- -1 carbamoyl halide Chemical class 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000002585 base Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000012223 aqueous fraction Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 4
- 229940031826 phenolate Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- BAYUSCHCCGXLAY-UHFFFAOYSA-N 1-(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(C(C)=O)=C1 BAYUSCHCCGXLAY-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 102000012440 Acetylcholinesterase Human genes 0.000 description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 239000005373 porous glass Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- DZZZXJVECUJDRB-UHFFFAOYSA-N 3-[2-(dimethylamino)ethyl]phenol Chemical compound CN(C)CCC1=CC=CC(O)=C1 DZZZXJVECUJDRB-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 229940124639 Selective inhibitor Drugs 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/50—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20023555A CZ293014B6 (cs) | 2002-10-24 | 2002-10-24 | Způsob výroby (-)-(S)-3-[1-(dimethylamino)ethyl]fenyl-N-ethyl-N-methylkarbamátu |
PCT/CZ2003/000058 WO2004037771A1 (en) | 2002-10-24 | 2003-10-21 | A method of production of (-)-(s)-3-[1-(dimethylamino)ethyl]phenyl-n-ethyl-n-methylcarbamate |
Publications (1)
Publication Number | Publication Date |
---|---|
UA79972C2 true UA79972C2 (uk) | 2007-08-10 |
Family
ID=29751096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200500538A UA79972C2 (uk) | 2002-10-24 | 2003-10-21 | Спосіб одержання (-)-(s)-3-[1-(диметиламіно)етил]феніл-n-етил-n-метилкарбамату та його гідротартрату |
Country Status (9)
Country | Link |
---|---|
US (1) | US7544840B2 (de) |
EP (1) | EP1556338B1 (de) |
AT (1) | ATE395330T1 (de) |
AU (1) | AU2003277795A1 (de) |
CZ (1) | CZ293014B6 (de) |
DE (1) | DE60321030D1 (de) |
EA (1) | EA006967B1 (de) |
UA (1) | UA79972C2 (de) |
WO (1) | WO2004037771A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2409453A (en) | 2003-12-24 | 2005-06-29 | Generics | Process for the preparation of aminoalkyl phenylcarbamates |
KR101168211B1 (ko) | 2004-11-08 | 2012-07-25 | 엠큐어 파마슈티컬즈 리미티드 | (s)-3-[(1-디메틸아미노)에틸]-페닐-n-에틸-n-메틸-카바메이트의 제조를 위한 효과적인 방법 |
KR20060072326A (ko) * | 2004-12-23 | 2006-06-28 | 동국제약 주식회사 | 페닐카바메이트 유도체의 새로운 합성 방법 |
ES2267399B1 (es) | 2005-08-04 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de carbamatos de fenilo. |
CN100391938C (zh) * | 2005-09-02 | 2008-06-04 | 上海奥博生物医药技术有限公司 | (s)-n-乙基-n-甲基-3-[1-(二甲氨基)乙基]-氨基甲酸苯酯(ⅰ)及其酒石酸盐(ⅱ)的制备方法 |
US7767843B2 (en) | 2006-03-02 | 2010-08-03 | Apotex Pharmachem Inc. | Process for the preparation of phenylcarbamates |
ATE472523T1 (de) * | 2006-08-17 | 2010-07-15 | Alembic Ltd | Verbessertes verfahren zur herstellung von rivastigmin |
WO2008037433A1 (en) | 2006-09-29 | 2008-04-03 | Synthon B.V. | Process for making aminoalkylphenyl carbamates and intermediates therefor |
EP1942100A1 (de) * | 2007-01-04 | 2008-07-09 | Krka Tovarna Zdravil, D.D., Novo Mesto | Amorphe und kristalline Formen von Rivastigminhydrogentartrat |
WO2008110339A2 (en) * | 2007-03-09 | 2008-09-18 | Synthon B.V. | Polymorphs of rivastigmine hydrogentartrate |
US8013181B2 (en) | 2007-04-10 | 2011-09-06 | Dr. Reddy's Laboratories Limited | Preparation of rivastigmine and its salts |
US7884121B2 (en) | 2007-06-11 | 2011-02-08 | Apotex Pharmachem Inc. | Process for the preparation of phenylcarbamates |
CN101910110B (zh) | 2008-01-10 | 2013-05-22 | 上海医药工业研究院 | 利凡斯的明的制备方法、其中间体以及中间体的制备方法 |
US8420846B2 (en) | 2008-08-25 | 2013-04-16 | Jubilant Life Sciences Limited | Process for producing (S)-3-[(1-dimethylamino)ethyl] phenyl-N-ethyl-N-methyl-carbamate via novel intermediates |
CN101823970B (zh) * | 2009-03-03 | 2013-05-08 | 江苏恩华药业股份有限公司 | 卡巴拉汀及其中间体的合成方法 |
CN101580482B (zh) * | 2009-05-27 | 2014-04-23 | 沈阳药科大学 | 一种重酒石酸盐卡巴拉汀的制备方法和应用 |
CN101613292B (zh) * | 2009-07-29 | 2013-05-22 | 上海医药集团股份有限公司 | (s)-3-(1-二甲氨基乙基)苯酚的制备方法 |
WO2011070585A1 (en) * | 2009-10-28 | 2011-06-16 | Shodhana Laboratories Limited | Processes for preparing rivastigmine, salts and intermediates thereof |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
WO2011151669A1 (en) | 2010-06-02 | 2011-12-08 | Jubilant Life Sciences Limited | Process for producing enantiomerically enriched isomer of 3-(1-aminoethyl) phenyl derivative and employing the same to produce rivastigmine or its pharmaceutically acceptable salt |
WO2011159910A2 (en) | 2010-06-17 | 2011-12-22 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol |
CN102786441B (zh) | 2011-05-18 | 2013-11-13 | 浙江海正药业股份有限公司 | 利凡斯的明的制备方法、其中间体以及中间体的制备方法 |
CN102285904B (zh) * | 2011-07-11 | 2013-06-05 | 中国科学院成都生物研究所 | 一种卡巴拉汀的制备方法 |
CN102898333A (zh) * | 2012-10-22 | 2013-01-30 | 哈药集团三精制药股份有限公司 | 一种重酒石酸卡巴拉汀的制备方法 |
CN103896787A (zh) * | 2012-12-26 | 2014-07-02 | 江苏康倍得药业有限公司 | 一种卡巴拉汀前体[1-(3-甲氧基苯基)乙基]二甲胺的制备方法 |
CN105254513A (zh) * | 2015-10-29 | 2016-01-20 | 无锡福祈制药有限公司 | (s)-3-[1-(二甲基氨基)乙基]苯酚(ⅲ)的拆分方法 |
CN106565543B (zh) * | 2016-10-14 | 2018-06-22 | 昆明源瑞制药有限公司 | 一种重酒石酸卡巴拉汀的制备方法 |
CN109507345B (zh) * | 2017-09-15 | 2022-08-05 | 万特制药(海南)有限公司 | 重酒石酸卡巴拉汀中间体及其杂质的分离测定方法 |
KR20200035359A (ko) | 2018-09-26 | 2020-04-03 | 캐딜라 파마슈티클즈 리미티드 | 리바스티그민 제조용 중간체의 합성 |
CN113461554A (zh) * | 2020-03-30 | 2021-10-01 | 北京泰德制药股份有限公司 | 一种卡巴拉汀中间体的纯化方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
-
2002
- 2002-10-24 CZ CZ20023555A patent/CZ293014B6/cs not_active IP Right Cessation
-
2003
- 2003-10-21 EA EA200500049A patent/EA006967B1/ru not_active IP Right Cessation
- 2003-10-21 EP EP03769173A patent/EP1556338B1/de not_active Expired - Lifetime
- 2003-10-21 WO PCT/CZ2003/000058 patent/WO2004037771A1/en active IP Right Grant
- 2003-10-21 DE DE60321030T patent/DE60321030D1/de not_active Expired - Fee Related
- 2003-10-21 UA UAA200500538A patent/UA79972C2/uk unknown
- 2003-10-21 US US10/523,927 patent/US7544840B2/en not_active Expired - Fee Related
- 2003-10-21 AT AT03769173T patent/ATE395330T1/de not_active IP Right Cessation
- 2003-10-21 AU AU2003277795A patent/AU2003277795A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CZ20023555A3 (cs) | 2004-01-14 |
DE60321030D1 (de) | 2008-06-26 |
US20060122417A1 (en) | 2006-06-08 |
EP1556338B1 (de) | 2008-05-14 |
CZ293014B6 (cs) | 2004-01-14 |
EA200500049A1 (ru) | 2005-06-30 |
EP1556338A1 (de) | 2005-07-27 |
WO2004037771A1 (en) | 2004-05-06 |
ATE395330T1 (de) | 2008-05-15 |
US7544840B2 (en) | 2009-06-09 |
EA006967B1 (ru) | 2006-06-30 |
AU2003277795A1 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA79972C2 (uk) | Спосіб одержання (-)-(s)-3-[1-(диметиламіно)етил]феніл-n-етил-n-метилкарбамату та його гідротартрату | |
AU2007278463B2 (en) | Preparation of 3-[(1R,2R)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol | |
JP3826208B2 (ja) | 光学純正アルブテロールの異性体選択性製剤 | |
EP1127871B1 (de) | Neuartige ester abgeleitet von substituierten phenyl-cyclohexyl-verbindungen | |
SK288185B6 (sk) | Stabilné soli derivátov 3,3-difenylpropylamínov | |
PT2010498E (pt) | Síntese de acilaminoalquenilenoamidas utéis como antagonistas da substância p | |
CN101321741A (zh) | 选择性合成经取代1-(2-氨基-1-苯基-乙基)-环己醇的对映异构体的方法 | |
AU2011222644A1 (en) | Improved resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol | |
TWI591045B (zh) | 作為有效藥劑成分之6-胺基己酸的製造方法 | |
EP2054373B1 (de) | Verbessertes verfahren zur herstellung von rivastigmin | |
WO2007026373A2 (en) | Process for preparing rivastigmine | |
ES2267399B1 (es) | Procedimiento para la obtencion de carbamatos de fenilo. | |
EP1926709A1 (de) | Verfahren zur herstellung einer chiralen 3-hydroxypyrrolidinverbindung und derivaten davon mit hoher optischer reinheit | |
DE60006125T2 (de) | Herstellung von 2-(2-arylmorpholin-2-yl)ethanolderivaten und zwischenprodukte | |
US8183272B2 (en) | Indanyl compounds | |
US7465830B2 (en) | Method of preparing pseudonorephedrine | |
WO1995026336A1 (fr) | Derives de n-(benzhydryloxyalkyl)-4-(carboxy/carbamoyl-methyl)-piperidine comme agents antidepressifs | |
US7763754B2 (en) | Process for producing (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol | |
Venkanna et al. | Deriving Atom Economy Approach by Employing Dynamic Resolution of (3-Methoxy Phenyl)-(3-N, N-Dimethyl Amino)-2-Methyl Propanone | |
WO2009141833A2 (en) | An improved process for synthesizing highly pure atomoxetine | |
JPH10330331A (ja) | デキスフェンフルラミン塩酸塩の製造法 | |
JP2002155035A (ja) | 3−アミノ−1−インダノール、その合成方法及びそれからなる光学異性体用分離剤 | |
SK278422B6 (en) | The production of tramadol of hydrogenchloride |